AUG 09, 2020 10:20 AM PDT

Reducing post-surgery metastasis in colorectal cancer patients

Scientists have recently shown the successful reduction of metastasis in post-surgery colorectal cancer patients. The study, reported in Cancer earlier this summer, concludes a three-year period during which researchers followed 34 patients receiving treatment for colorectal cancer.

The Tel Aviv University scientists leading the study administered medication to the patients during the pre- and post-surgical period in order to monitor corporal stress responses and physiological inflammation. The drugs administered were Propranolol (Deralin), an anti-anxiety and blood pressure reducing dru, and Etodolac (Etopan), an anti-inflammatory analgesic. The patients received them starting five days before surgery throughout the two weeks following the surgery. Half of the patients were administered a placebo treatment as a control group.

Reducing stress and inflammation aided in impeding the development of metastases, say the researchers. "When the body is in a state of stress, whether physiological (from surgery) or psychological, this causes a release of high amounts of two types of hormones, prostaglandins and catecholamines," explains Professor Shamgar Ben-Eliyahu from TAU's School of Psychological Sciences and Sagol School of Neuroscience.

"These hormones suppress the activity of the immune cells, indirectly promoting the development of cancer metastases. In addition, these hormones also directly promote the acquisition of metastatic traits in cancer tissue. Our study shows that inexpensive, accessible medication treatment could be used in order to reduce body stress responses and inflammation associated with surgery, which affects the tumor, significantly reducing the risk of metastases that might be detected months or years after surgery."

Photo: Pixabay

Together with Professor Oded Zmora from Shamir (Assaf Harofeh) Medical Center, Professor Ben-Eliyahu found that 12.5% (2 out of 16) of patients administered the drug treatment showed metastasis, compared to 33% (6 out of 18 patients) in the control group. While the findings suggest significant improvement, the researchers say that in order to confirm their findings further tests with larger populations should be established.

The team analyzed cancerous tissues from the patients to determine how the medications reduced metastasis. They found that the medications positively affect in the number and type of infiltrating tumor leukocytes, creating a microenvironment that is hostile to cancer cells’ growth.

Sources: Cancer, Eureka Alert

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
NOV 18, 2020
Genetics & Genomics
Choosing an NGS workflow: What are you looking for?
NOV 18, 2020
Choosing an NGS workflow: What are you looking for?
  It’s easy to be overwhelmed by the number of workflows that are available for NGS. How do you choose? While ...
NOV 20, 2020
Cancer
How does tissue geometry influence cancer cellular migration?
NOV 20, 2020
How does tissue geometry influence cancer cellular migration?
A team of researchers led by UC Santa Barbara's Distinguished Professor Denise Montell has recently published new fi ...
DEC 16, 2020
Cancer
More young adults are being diagnosed with esophageal adenocarcinoma
DEC 16, 2020
More young adults are being diagnosed with esophageal adenocarcinoma
New research published in a journal of the American Association for Cancer Research, Cancer Epidemiology, Biomarkers &am ...
DEC 23, 2020
Cancer
Using AI to identify new measures of mammography
DEC 23, 2020
Using AI to identify new measures of mammography
New findings published in the International Journal of Cancer from the University of Melbourne report that new mamm ...
DEC 24, 2020
Genetics & Genomics
After Chromosomes Shatter, Cancer Cells Can Become Drug-Resistant
DEC 24, 2020
After Chromosomes Shatter, Cancer Cells Can Become Drug-Resistant
Many types of cells have to be replenished throughout our lives, and cells divide to replace those that are damaged or w ...
DEC 31, 2020
Cancer
Does inflammation make ADT symptoms worse?
DEC 31, 2020
Does inflammation make ADT symptoms worse?
A new study published in the journal Cancer considers the impact of inflammation on prostate cancer patients underg ...
Loading Comments...